Global X Genomics & Biotechnology ETF
GNOM
GNOM
63 hedge funds and large institutions have $128M invested in Global X Genomics & Biotechnology ETF in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $138M → $128M (-$10.4M)
Holders
63
Holding in Top 10
–
Calls
$17K
Puts
–
Top Buyers
| 1 | +$644K | |
| 2 | +$359K | |
| 3 | +$339K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$220K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$208K |
Top Sellers
| 1 | -$7.81M | |
| 2 | -$762K | |
| 3 | -$464K | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$422K |
| 5 |
IA
Insight Advisors
Newtown,
Pennsylvania
|
-$264K |